Applicable Symptoms: This product is a non-steroidal anti-inflammatory drug and is used when treatment with at least one other non-steroidal anti-inflammatory drug has failed. It can be used for the treatment of the pain of chronic arthritis (such as osteoarthritis) and the pain after surgery and acute trauma, as well as the symptoms of primary dysmenorrhea.
Applicable Symptoms: Indicated for gastric and duodenal ulcers
Applicable Symptoms: Glipizide is used as supplementary means for diets and exercises to improve glycemic control in adults with type 2 diabetes.
Applicable Symptoms: This product is indicated for the treatment and prevention of infections identified or suspected to be caused by anaerobic bacteria. This product has inhibitory activities against a variety of pathogenic microorganisms, especially Bacteroides, Fusobacteria, Clostridium, Eubacteria, Peptococcus, Peptostreptococcus, Anaerococcus and Gardnerella vaginalis. It also has therapeutic effects against Trichomonas vaginalis, Entamoeba histolytica Schaudinn, Giardia lamblia, Balantidium coli and Dracunculus medinensis. The indications of this product for adults and children are as follows: 1. Anaerobic infection (1) For the prevention of postoperative anaerobic infections, especially the infections caused by Bacteroides and P. anaerobius (2) For the treatment of skin and soft tissue infections, bone and joint infections (as an adjuvant therapy), endocarditis, sepsis, bacteremia, peritonitis, abdominal abscess, liver abscess, meningitis, brain abscess, necrotizing pneumonia, empyema, lung abscess, osteomyelitis, puerperal cerebral toxemia, pelvic abscess, pelvic cellulitis, endometritis, endomyometritis, tubo-ovarian abscess, postoperative vaginal uterine infection, and postoperative wound infection where pathogenic anaerobic bacteria can be isolated or highly suspected concurrent anaerobic infection is present. (3) For the treatment of leg ulcers and pressure sores caused by anaerobic bacteria infections. 2. Trichomoniasis (1) For the treatment of female (trichomonas vaginitis, urethral trichomoniasis, etc.) and male patients with urogenital trichomoniasis. (2) For the treatment of asymptomatic sexual partners. 3. Bacterial vaginosis (also known as nonspecific vaginitis, anaerobic vaginitis or Gardnerella vaginitis). 4. Amoebiasis For the treatment of all forms of amoebiasis, including intestinal and parenteral amoebiasis (such as amebic liver abscess, pleural amoebiasis), as well as asymptomatic amoebiasis. 5. Oral infection (1) For the treatment of ulcerative gingivitis. (2) For the treatment of odontogenic infections (such as acute periodontitis and acute periapical periodontitis). 6. Giardiasis, balanomiasis, dermal leishmaniasis anddracunculiasis, etc. To reduce the production of drug-resistant bacteria and ensure the efficacy of metronidazole tablets and other antibacterial drugs, metronidazole tablets shall be limited to the treatment or prevention of infections that have been proved or are strongly suspected to be caused by bacteria. Official guidelines shall also be referred to for the rational use of antibacterial drugs.
Applicable Symptoms: 1. This product is indicated for the treatment and control of benign prostatic hyperplasia (BPH) and the prevention of urinary system diseases: -Reducing the risk of acute urinary retention. -Reducing the risk of requirements for transurethral resection of the prostate (TURP) and prostatectomy. 2. This product can shrink the enlarged prostate and improve urine flow and BPH-related symptoms. This product is indicated for the patients with prostatic hyperplasia.
